FOLH1 and prostate carcinoma: 68Ga-PSMA-11 digital PET/CT showed a superior performance compared to analog PET/CT in restaging prostate cancer patients with early biochemical recurrence/persistence, leading to a higher detection rate especially at lower PSA values (≤1 ng/mL).